A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Upcommimg biotech with a first in class drug due to expand its fda indications. They have pricing power, an off the beaten path pipeline, international presence and good marketing reach in the US. They face no competition for their indications, think Genzyme, only more focused. Could be an acquisition too.